Step-by-Step Approach for Febrile Infants
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۹۰ • واحد: days
حداقل ۰ — حداکثر ۱۰۰ • واحد: ng/mL
حداقل ۰ — حداکثر ۵۰۰ • واحد: mg/L
حداقل ۰ — حداکثر ۱۰۰۰۰۰ • واحد: /mm³
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low risk0–0
- Not low risk1–1
The Step-by-Step Approach for Febrile Infants calculates calculating weight-based pediatric dosing and evaluating age-specific physiological parameters. Key inputs include ill appearing. Scores guide titrating weight-adjusted medication dosing, monitoring developmental safety, and evaluating treatment response. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Step-by-Step approach (Gomez 2016) to identify febrile infants ≤90 days at low risk of invasive bacterial infection (bacteremia/meningitis). Sequential rule: ill appearance, age ≤21 days, leukocyturia, procalcitonin ≥0.5 ng/mL, or CRP >20 mg/L / ANC >10,000 per mm³ each classify the infant as NOT low risk; otherwise low risk.
Clinical Indication
The Step-by-Step Approach for Febrile Infants is indicated for bedside clinical practice to support Step-by-Step approach (Gomez 2016) to identify febrile infants ≤90 days at low risk of invasive bacterial infection (bacteremia/meningitis). Sequential rule: ill appearance, age ≤21 days, leukocyturia, procalcitonin ≥0.5 ng/mL, or CRP >20 mg/L / ANC >10,000 per mm³ each classify the infant as NOT low risk; otherwise low risk.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Neonates, infants, children, and adolescents from birth up to 18 years of age. Clinical application is indicated across Pediatric emergency departments, pediatric inpatient wards, PICU, and pediatric primary care.
Limitations & Contraindications
Adult scoring thresholds and pharmacological formulas must never be applied to pediatric patients. Clinical exclusion: Applies ONLY to well-defined population: febrile infants ≤90 days old without an evident source; excludes preterm, ill-defined, or previously treated infants per the original study criteria..
Clinical Pearls & Action Plan
Accurate weight-based dosing and age-stratified physiological vital sign reference ranges are foundational in pediatric clinical practice. Guideline pearl: Original validation: Gomez B et al. Pediatrics. 2016;138(2):e20154381..
Sequential: ill-appearing? -> not low risk | age <= 21d? -> not low risk | leukocyturia? -> not low risk | procalcitonin >= 0.5? -> not low risk | CRP > 20 or ANC > 10000? -> not low risk | else LOW RISK
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| ill_appearing | string | Yes | Infant appears ill on examination |
| age_days | integer | Yes | Age in days (must be ≤90 for this approach)(days) |
| leukocyturia | string | Yes | Leukocyturia on urine dipstick/urinalysis |
| procalcitonin | float | Yes | Serum procalcitonin(ng/mL) |
| crp | float | Yes | C-reactive protein(mg/L) |
| anc | float | Yes | Absolute neutrophil count(/mm³) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Low risk | Low risk of invasive bacterial infection |
| 1–1 | Not low risk | Not low risk - requires full evaluation |
Evidence-Based References (EBM)
- Gomez B, Mintegi S, Bressan S, et al. Validation of the 'Step-by-Step' Approach in the Management of Young Febrile Infants. Pediatrics. 2016;138(2):e20154381.